Libanier was only 6 years old when he was hit by a car. Even though he experienced a typical childhood, at the age of 16 he began to feel very weak and was diagnosed with post traumatic syringomyelia.
In June 2014, while traveling to the Dominican Republic, he started having trouble with his breathing. Over the next few months his breathing worsened, and in September, 2014, Dr. Mark Ginsburg implanted Libanier with the Diaphragm Pacing System at New York Presbyterian Hospital.
Libanier now enjoys going to the movies, hanging out with friends and having a more independent life. Libanier states, “I am extremely happy and feel blessed to have the diaphragm pacing system; I can’t imagine how my life would have been without it.”
The Avery Diaphragm Pacing System is an implanted phrenic nerve or diaphragm stimulator. It consists of surgically implanted electrodes and receivers with an external transmitter and antennas.
The Avery Diaphragm Pacing System is the only diaphragm pacing system to have full premarket approval (PMA) from the US FDA and CE Marking privileges under the European Active Implantable Medical Device Directive for adult and pediatric use. In addition, using small implanted radio frequency receivers rather than electrode wires that pass directly through the skin may decrease a patient’s risk of infection and ongoing wound care management issues.
Avery has been commercially distributing diaphragm pacing systems since the early 1970’s. Since then, more than 2,000 patients have been implanted in over 40 countries establishing an unsurpassed record of safety and reliability. Due to their high reliability and cost effectiveness, the Avery pacers are reimbursed by Medicare and most private and government insurance around the world.